PROPANC BIOPHARMA, INC. Share-based Payment Arrangement, Amount Capitalized
PROPANC BIOPHARMA, INC. (PPCB) reported Share-based Payment Arrangement, Amount Capitalized of $0 for the 6-month period ending 2023-12-31, per its 10-Q filed 2024-02-20.
Discontinued › Notes › Share-Based Payment Arrangement
us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount · last filed 2024-02-20
- PROPANC BIOPHARMA, INC. share-based payment arrangement, amount capitalized for the quarter ending 2023-12-31 was $0.00.
- PROPANC BIOPHARMA, INC. share-based payment arrangement, amount capitalized for the quarter ending 2023-09-30 was $0.00.
- PROPANC BIOPHARMA, INC. share-based payment arrangement, amount capitalized for the quarter ending 2022-12-31 was $0.00.
- PROPANC BIOPHARMA, INC. share-based payment arrangement, amount capitalized for the quarter ending 2022-09-30 was $0.00.
- PROPANC BIOPHARMA, INC. share-based payment arrangement, amount capitalized for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- PROPANC BIOPHARMA, INC. share-based payment arrangement, amount capitalized for fiscal 2022 was $72.51K.
| Period end | Share-based Payment Arrangement, Amount Capitalized 3 month | Share-based Payment Arrangement, Amount Capitalized 6 month | Share-based Payment Arrangement, Amount Capitalized 12 month |
|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-20 | $0.00 10-Q · filed 2024-02-20 | |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-14 | ||
| 2023-06-30 | $0.00 10-K · filed 2023-09-28 | ||
| 2022-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-20 | $0.00 10-Q · filed 2024-02-20 | |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-14 | ||
| 2022-06-30 | $72.51K 10-K · filed 2023-09-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |